Ranked #1
Emerging Therapies
Emerging Therapies
Data from AAN 2011 on emerging MS therapies, including laquinimod, cladribine, alemtuzumab, and more.
28 Apr 2011
•
10mins
Ranked #2
Current Therapies
Current Therapies
Data from AAN 2011 on current MS therapies, including interferon beta, glatiramer acetate, natalizumab, mitoxantrone, an... Read more
28 Apr 2011
•
9mins
Ranked #3
Cognitive Dysfunction
Cognitive Dysfunction
New research on MS-related cognitive dysfunction from AAN 2011.
28 Apr 2011
•
7mins
Ranked #4
Testing, Imaging, Biomarkers, and Predictors
Testing, Imaging, Biomarkers, and Predictors
Reports from AAN 2011 on evolving applications of imaging and testing in MS.
28 Apr 2011
•
11mins
Ranked #5
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 2
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 2
Latest research from AAN 2011 on mechanisms of disease progression in MS.
28 Apr 2011
•
5mins
Ranked #6
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 1
Pathophysiology, Immunology, Genetics, Neuropreservation - Part 1
Latest research from AAN 2011 on risk factors for and pathogenesis of MS.
28 Apr 2011
•
9mins